Marvell Priced Its Lumentum Deal at About $1,132 a Share. At Tuesday's Close, the 4.5 Marvell Shares Behind It Were Worth About $774.

On Monday, November 2, 2026, Marvell and Lumentum said they will combine in an all-stock deal with an implied enterprise value of $115 billion for Lumentum. Each Lumentum share becomes 4.500 Marvell shares. The joint release puts that at about $1,132 per Lumentum share, a premium of about 23.9 percent.

The number that matters more is in the footnote to that premium. It is "based on each company's unaffected closing share price as of October 28, 2026," the last trading day before speculation began. Marvell's stock has not been anywhere near that price since.

What Was Announced

• Structure: a fixed exchange ratio of 4.500 Marvell shares per Lumentum share, no cash. Marvell holders would own about 67 percent of the combined company and Lumentum holders about 33 percent, fully diluted.
• Pitch: Marvell's electrical and optical interconnect, switching and custom silicon, plus Lumentum's lasers, optical transceivers and optical circuit switching (OCS), aimed at what the companies call a $550 billion market. They see a line of sight to more than $1 billion of annual run-rate cost synergies.
• People: Matt Murphy stays chairman and CEO. Three Lumentum directors, including CEO Michael Hurlston, join Marvell's seven-member board.
• Timing: close expected in the first half of calendar 2028, after both shareholder votes and regulatory approvals. Marvell's 8-K sets an outside date of November 1, 2027, extendable to February 1, May 1 and August 1, 2028 if regulatory approvals are still pending.
• Breakup terms: Marvell owes Lumentum $5.8 billion if its board withdraws its recommendation or it takes a superior proposal, and a $3.2 billion regulatory termination fee in certain regulatory failure cases.

Murphy called the move to optical connectivity "an opportunity that comes along once in a generation." TechCrunch calls it one of the largest deals in tech history. The $115 billion headline is bigger than Microsoft's $68.7 billion Activision Blizzard purchase and Dell's $67 billion EMC deal, the two comparisons TechCrunch drew. Reuters, via TNW, says it is Marvell's largest acquisition since its $10 billion Inphi deal in 2021.

The Currency Moved First

Bloomberg reported the talks late on Wednesday, October 28. The selling started Thursday and ran through Monday. Here are the closing prices, with the deal's implied value per Lumentum share at each close.

Closing prices are from Yahoo Finance market data and match the moves CNBC, heise, Benzinga and the Motley Fool reported. Percentages and the implied value column are our arithmetic. Four and a half times the October 28 Marvell close is $1,132.43, which is how the release got its figure.

Over the three sessions from October 29 through November 2, Marvell lost about 31.9 percent. Benzinga reports that was its worst three-day stretch since October 2000 and estimates it erased about $66 billion of market value. That is more than all of Lumentum, which was worth roughly $61 billion at Tuesday's close by our math from the market values Bloomberg reported.

The fixed ratio means Lumentum holders took the hit too. At Tuesday's close, the offer was worth about $774 per Lumentum share, roughly 32 percent below the headline $1,132 and about 15 percent below where Lumentum traded before anyone knew about the talks. The "23.9 percent premium" is now a discount.

What the Analysts Said

• Bank of America: analyst Vivek Arya cut Marvell to Neutral from Buy and the target to $225 from $400. Per Investing.com, the firm wrote that "$1 billion in planned cost cuts would be insufficient to offset approximately 50% dilution in share count," and flagged customer conflicts: Marvell sells chips to optical module makers that Lumentum competes with in transceivers.
• TD Cowen: analyst Sean O'Loughlin cut Marvell to Hold from Buy and the target to $175 from $350, citing a "negative view of the transaction itself in terms of structure and timing," and worried the deal lands near the peak of an optical mini-cycle.
• IG Group: "This is an enormous bet and investors are right to ask if Marvell is paying too much and taking on too much at once," analyst Axel Rudolph told Reuters, as quoted by heise.

Bank of America also noted that Marvell did not mention large M&A at its recent analyst day. And the timing was rough for any chip deal: the firm put the Philadelphia Semiconductor Index down 19 percent over the past month.

The Nvidia Thread

Nvidia sits on both sides. On March 2, Nvidia said it would invest $2 billion in Lumentum, alongside a multi-year commitment to buy several billion dollars of advanced laser components. On March 31, it put $2 billion into Marvell as part of a partnership that includes NVLink Fusion custom silicon and optical interconnect work. Bloomberg reported that Jensen Huang backed the merger.

Murphy waved off the "circular" dealmaking critique on CNBC: "This is a double down on supporting Nvidia, who is the ecosystem leader in this area." That is a frank answer. It also names the risk. The combined company would be a bigger supplier to one dominant buyer that already holds equity in both halves.

Our Take

The strategy is easy to defend. Murphy's case is that AI infrastructure is shifting toward optical connectivity, and Lumentum brings indium phosphide laser manufacturing at a time when even a skeptic like BofA talks about laser shortages. Owning the laser fab and the silicon that drives it is a coherent bet. I would not argue with the direction.

The price and the payment are another matter. Marvell agreed to pay in its own stock right after that stock had climbed to a level the market immediately refused to defend. The $115 billion figure describes a moment that ended late on October 28. Anyone quoting it today is quoting a number neither company's shareholders can get.

The spread tells you the rest. At Tuesday's close, Lumentum traded about 12 percent below the $774 the deal would pay today. Part of that is the long wait: the outside date can stretch to August 2028. Part of it is doubt that the deal closes at all. BofA's line about laser shortages being "inevitably resolved" is the sharpest version of that doubt. If the shortage that makes Lumentum precious eases before 2028, Marvell will have grown its share count by about half, per BofA, for a business TD Cowen worries it is buying near the peak of a cycle.

My read: this is an Nvidia supply-chain consolidation financed by Marvell shareholders. It may still be the right long-term move. But the market voted on the structure in three sessions, and the vote was about $66 billion against.

Three Signposts for the Next 60 Days

First, whether Marvell changes terms or adds a buyback to answer the dilution math, or holds the fixed ratio as signed. Second, which regulators beyond the US Hart-Scott-Rodino review appear in the proxy, and how long they look. Third, whether the spread between Lumentum's price and the implied deal value narrows or widens as Marvell reports its October quarter, which it says is in line with guidance.

Sources: Marvell and Lumentum joint release (SEC exhibit 99.1), Marvell 8-K, Nvidia and Lumentum release, March 2, SiliconANGLE on Nvidia and Marvell, CNBC, TechCrunch, TNW (talks report), heise, Investing.com (analyst roundup), Benzinga, The Motley Fool.